Organic Medicinal Chemist with Expertise in the Synthesis and Design of Medicinal Drug CandidatesMedicinal Chemist with a proven track record of success in the synthesis and design of medicinal drug candidates.Provide creative and innovative solutions to chemistry challenges including the safe design, conduct, interpretation and technical evaluation.Significant synthetic research experience in multi-step milligram to multigram quantities of intermediates and products, diversity design, crystallographic modeling and experience with protein-protein interactions.Molecule design in partnership with pharmacology and moving projects forward in a...

Medicinal Chemist Consultant for API Process Research, Development and API Process Start-upSynthetic organic chemist and small scale chemical process research and development.Chemical process research and development for "small molecule" drug substances.Guidance for scale-up to provide material for Phases 1 - 3 and manufacturing.Pharmaceutical facility start-up troubleshooting.Assistance with CMC section of filings.Pharmaceutical laboratory process research leading to technology transfer and scale up.Design and implementation of practical, cost-saving, processes and procedures.Experienced with 12 hands-on manufacturing start-ups of drug su...

Pharmaceutical Chemistry Consultant for Drug Discovery, ADME, and Drug Toxicity and Drug SafetyPharmaceutical drug discovery process and implementation.Drug discovery and medicinal chemistry.Preclinical pharmacology, ADME (absorption, distribution, metabolism, and excretion of drugs) and pharmaceutical toxicology and safety.Pharmaceutical drugs for anti-infectives, anti-virals, oncology and immunology.Pharmaceutical drugs for cardiovascular and metabolic disease.Pharmaceutical drugs for diabetes, obesity, aging and frailty.Due diligence assessments, including intellectual property.

Functional properties of IgA. Development of oral vaccine delivery technologies. Effectiveness of host-parasite relationships. Mechanisms of adherence and pathogenisis. Development of oral drug delivery systems. Development of biodegradable nanoparticles, tumor targeting agents, transdermal drug delivery systems, and oral nanolattices for protein drugs.Functional properties of IgA.Development of oral vaccine delivery technologies.Effectiveness of host-parasite relationships.Mechanisms of adherence and pathogenisis.Transport of macromolecules across the intestinal epithelium.Receptor mediated endocytosis.Isolation, purification and refoldi...